129 related articles for article (PubMed ID: 2358856)
21. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
[TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical evaluation of proliferative activity in human brain tumours.
Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
Anal Cell Pathol; 1990 Sep; 2(5):269-75. PubMed ID: 2275874
[TBL] [Abstract][Full Text] [Related]
23. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
24. [The evaluation of cell proliferation in gliomas].
Alkiza K; Adán B; Garibi JM; Lafuente JV
Rev Neurol; 2000 Jan 16-31; 30(2):141-6. PubMed ID: 10730321
[TBL] [Abstract][Full Text] [Related]
25. Estimation of growth fraction in situ in human bladder cancer with bromodeoxyuridine labelling.
Nemoto R; Hattori K; Uchida K; Shimazui T; Koiso K; Harada M
Br J Urol; 1990 Jan; 65(1):27-31. PubMed ID: 2310929
[TBL] [Abstract][Full Text] [Related]
26. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
27. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
28. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
29. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Maeda T; Hoshino T
No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
[TBL] [Abstract][Full Text] [Related]
30. Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Falchetti ML; Pallini R; Larocca LM; Verna R; D'Ambrosio E
J Clin Pathol; 1999 Mar; 52(3):234-6. PubMed ID: 10450187
[TBL] [Abstract][Full Text] [Related]
31. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
32. In-vivo proliferative potential of primary human brain tumors; its correlation with histological classification and morphological features: I. Gliomas.
Dinda AK; Kharbanda K; Sarkar C; Roy S; Mathur M; Banerji AK
Pathology; 1993 Jan; 25(1):4-9. PubMed ID: 8316498
[TBL] [Abstract][Full Text] [Related]
33. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai WC; Hueng DY; Nieh S; Gao HW
J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
[TBL] [Abstract][Full Text] [Related]
34. Metallothionein overexpression in human brain tumours.
Maier H; Jones C; Jasani B; Ofner D; Zelger B; Schmid KW; Budka H
Acta Neuropathol; 1997 Dec; 94(6):599-604. PubMed ID: 9444362
[TBL] [Abstract][Full Text] [Related]
35. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
36. Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro.
Engebraaten O; Bjerkvig R; Lund-Johansen M; Wester K; Pedersen PH; Mørk S; Backlund EO; Laerum OD
Acta Neuropathol; 1990; 81(2):130-40. PubMed ID: 2082653
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric analysis of DNA ploidy and proliferative potential in brain tumours.
Gasińska A; Krzyszkowski T; Skołyszewski J; Biesaga B; Gliński B; Pyrich M
Folia Histochem Cytobiol; 1998; 36(3):133-8. PubMed ID: 9773297
[TBL] [Abstract][Full Text] [Related]
38. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity].
Oriuchi N; Tamura M; Shibazaki T; Inoue T; Watanabe N; Tateno M; Tomiyoshi K; Hirano T; Igarashi H; Endo K
Kaku Igaku; 1991 Nov; 28(11):1263-71. PubMed ID: 1770641
[TBL] [Abstract][Full Text] [Related]
40. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
